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Abstract The intestinal microbiota of the horse, an animal of huge economic and 21 
social importance worldwide, is essential to the health of the animal. Understanding 22 
the intestinal ecosystem and its dynamic interaction with diet and dietary supplements 23 
currently requires the use of experimental animals with consequent welfare and 24 
financial constraints. Here, we describe the development and assessment, using 25 
multiple analytical platforms, of a three vessel, continuous flow, in vitro model of the 26 
equine hindgut. After inoculation of the model with fresh horse feces, bacterial 27 
communities established in each vessel that were taxonomically similar to those in the 28 
source animal. Short chain and branched chain fatty acid (SCFA/BCFA) production 29 
within the model at steady-state was consistent with expected bacterial function 30 
although higher concentrations of some SCFA/BCFAs, were apparent relative to that 31 
of ex vivo gut content. We demonstrate inter-model repeatability and the ability of the 32 
model to capture some aspects of individual variation in bacterial community profiles. 33 
This proof-of-concept study, including recognition of model limitations, supports its 34 
future development as a tool for investigating the impact of disease, nutrition, dietary 35 
supplementation and medication on the equine intestinal microbiota. 36 
Importance The equine gut model that we have developed and described has the 37 
potential to facilitate the exploration of how the equine gut microbiota is affected by 38 
diet, disease and medication. It is a convenient, cost-effective and welfare-friendly 39 
alternative to in vivo research models. 40 
 41 
INTRODUCTION 42 
Commensal bacteria that reside within the large intestine of the equine gastrointestinal 43 
tract are vital for the horse to be able to utilise a forage-based diet. Some of these 44 
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bacteria produce short chain fatty acids (SCFAs), which are absorbed through the gut 45 
wall and contribute to the energy requirements of the horse. Sequencing of bacterial 46 
16S rRNA genes from gastrointestinal content or feces has been used to profile the 47 
gut microbiota of healthy horses (1–5) and to assess the impact of diseases such as 48 
colitis and grass sickness on equine fecal bacterial communities (6,7). In common with 49 
the majority of human microbiota studies, most disease-related studies have 50 
characterized the equine fecal microbiota due to ease of access to samples. Equine 51 
feces have been shown to be broadly representative of bacterial communities within 52 
distal parts of the large colon (1) and to more orad parts of the intestinal tract. 53 
To accurately analyze bacterial communities within the gastrointestinal tract of 54 
the horse, direct sampling of each region of interest would be ideal. While this can be 55 
done post-mortem or with fistulated horses, both techniques have limited application 56 
due to financial, ethical and welfare implications. Therefore, a fermentation model 57 
representing the microbiota of the equine large intestine in vitro would facilitate this 58 
important area of equine health research, enhancing our ability to explore the impact 59 
of diet, pathogens, novel foodstuffs, dietary supplements and drugs on the equine gut 60 
microbiota. 61 
 Models of the human gut have been a valuable and widely used research tool 62 
(8). Studies have shown how an intervention with galactooligosaccharide (GOS) has 63 
similar effects on the microbial community in vitro when compared to in a human study 64 
population (9). In vitro and in vivo approaches were taken to study the effect of the 65 
prebiotic GOS on the gut microbiota of children with autism (10,11). Both approaches 66 
demonstrated an increase in butyrate production (in the gut model and human feces 67 
respectively) suggesting that the model is metabolically valid. Gut models have 68 
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provided preliminary insights on the effects of dietary supplement or drug on the 69 
human gut microbiota before commencing costly human trials. 70 
In vitro fermentation models developed to represent bacterial activity in the 71 
equine gastrointestinal tract have been reported previously (12–20). However, the 72 
majority of these models have used a simple medium or equine feed to maintain fecal 73 
bacterial populations and do not replicate the continuous flow of ingesta through the 74 
gastrointestinal tract (12,13,16–22). These models often use gas production as a 75 
marker of bacterial function and measure the kinetic properties of the bacterial 76 
populations cultured (13,17–21). Sequencing of bacterial DNA from fermentation 77 
samples allows for a more comprehensive overview of the bacterial communities 78 
present, however this approach has so far only been reported in one equine 79 
fermentation study (14). 80 
In this study, we report on the development and performance of a three-stage 81 
fermentation model designed to simulate bacterial communities in the equine large 82 
intestine. Two experiments were designed: i) a concordance study of three individual 83 
gut models, each inoculated with feces from a different horse (post-mortem), to 84 
evaluate the extent to which the gut bacterial profiles of individual horses are 85 
replicated, and  ii) a repeatability study of two gut models inoculated with feces from 86 
the same horse (pre-mortem). To analyse samples taken from the vessels of the gut 87 
model we used fluorescence in situ hybridization (FISH) analysis to assess total 88 
bacterial numbers and 16S rRNA bacterial gene sequencing to characterize the 89 
microbial community profile in vitro, compared to the samples taken ex vivo. Proton 90 
nuclear magnetic resonance (1H NMR) spectroscopy and gas chromatography were 91 
used to measure a broad range of metabolites to evaluate the functional activity of the 92 
model microbiota. Specifically we report on i) model concordance with in vivo gut 93 
5 
 
bacterial populations, ii) repeatability of the model, and iii) the ability of the model to 94 
capture individual variation in bacterial community profile. 95 
 96 
RESULTS 97 
Gut model medium was adapted to reflect a normal equine diet 98 
The acid detergent fibre (ADF) and starch content of gastrointestinal content samples 99 
were analyzed to inform the compositional changes made to the gut model media. We 100 
aimed to replicate the diet of the average UK leisure horse in the media used to feed 101 
the model and the horses sampled to inoculate it. A large percentage of the 102 
gastrointestinal content of the equine ileum, large colon and feces was acid detergent 103 
fibre (ADF, Figure S1). Feces had the highest percentage of ADF (42.9 % ± 3.9 %) 104 
and the lowest percentage of starch (0.56 % ± 0.49 %), whereas the ileal content had 105 
the lowest percentage of ADF (25.9 % ± 10.8 %) and the highest percentage of starch 106 
(3.8 % ± 3.3 %). The analysis of ADF and starch from ileum content informed the 107 
cellulose and starch content of the gut model media used to feed the model. 108 
 109 
The equine in vitro gut model can support a metabolically functioning bacterial 110 
population 111 
The concentrations of five short chain and branched chain fatty acids (SCFA/BCFA) 112 
produced in each vessel of the in vitro gut models were measured during the 113 
concordance study to assess the metabolic output of bacterial fermentation. Figure 1 114 
shows the concentration of acetate, propionate, butyrate, isobutyrate and valerate in 115 
the three vessels, as a mean of the three separate gut models. Concentrations of 116 
6 
 
acetate and propionate rose quickly in all three vessels after initial inoculation (Figure 117 
1A and B). Concentrations of butyrate, isobutyrate and valerate only increased 118 
marginally between T-1 and T0, but then increased sharply after the flow of media 119 
wasstarted at T0 (Figure 1C, D and E). The mean concentration for all SCFA/BCFA 120 
measured was observed to stabilise in all three vessels by T5 as there was no 121 
significant change in concentration between T3 and T5 (p > 0.05). 122 
 The metabolic profiles of the three gut models in the concordance study were 123 
compared to that of the gastrointestinal content of the donor horses. Figure 2 shows 124 
the PCA model (R2 = 0.64) built with metabolic data from gastrointestinal contents, 125 
feces from the rectum and all samples taken from the three gut models. The PCA 126 
scores plot shows that the largest source of variation within the dataset (PC1, 127 
representing 50 % of the total variation the dataset) was explained by samples taken 128 
from the model after T1 having higher concentrations of acetate (Figure 2A and B). 129 
Within the second principle component (PC2) of this PCA model samples of 130 
gastrointestinal content clustered away from samples from the gut models 131 
(representing 15 % of the total variance, Figure 2A). This was due to the content of 132 
the large colon having higher concentration of acetate compared to the gut model 133 
(Figure 2C). 134 
 A PCA model was constructed with the metabolic profiles of the gastrointestinal 135 
content and samples taken from the three concordance  study models at T5 (R2 = 136 
0.64). There was separation of points representing samples from the two groups in 137 
PC1 (explaining 48 % of the variance in the dataset) in the PCA scores plot (Figure 138 
S2A) indicating metabolic differences between samples of gastrointestinal content and 139 
gut model. When these differences were explored further, samples of gastrointestinal 140 
content had higher concentrations of acetate whereas the samples from the gut model 141 
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at T5 had higher levels of valerate and propionate (Figure S2B). An OPLS-DA model 142 
was also built with the metabolic spectra from these two groups of samples (Q2Y = 143 
0.82). This supervised model showed the differences in levels of acetate, propionate 144 
and valerate (also evident in the PCA model) alongside higher levels of diethylene 145 
glycol (DEG), ethanol, trimethylamine (TMA) and iso-valerate in samples from the gut 146 
models (Figure S2C). 147 
 148 
The equine gut model can replicate part of the equine large intestinal microbiota 149 
An estimate of total bacteria was created using FISH analysis to assess bacterial 150 
concentration within the gut model after fecal inoculation. Mean total bacteria for the 151 
three gut models of the concordance study were lower in the vessels of the gut model 152 
at T-1 (2.68 x 108, 2.86 x 108, 2.21 x 108 bacteria per ml) compared to gastrointestinal 153 
content (3.93 x 108, 3.40 x 108, 3.32 x 108 bacteria per ml). At T0 bacterial counts had 154 
risen in all three vessels (2.81 x 108, 4.02 x 108, 3.69 x 108 bacteria per ml). By T5 155 
(steady state) bacterial proliferation had plateaued, with vessel one having the highest 156 
counts (5.51 x 108 bacteria per ml) and vessel three the lowest (3.74 x 108 bacteria 157 
per ml). Bacterial alpha diversity (measured as observed OTUs) within the gut models 158 
at T0 and T5 was significantly lower than the bacterial diversity of gastrointestinal 159 
content and the models at T-1 (p < 0.05, Figure S3A) 160 
 Unsurprisingly bacterial community profile at phylum level of the model at T-1 161 
(immediately after inoculation) was similar of that of gastrointestinal content of the 162 
horses that provided feces for inoculation (Figure 3). However, the abundance of 163 
Verrucomicrobia was greater in the in vitro gut models immediately after inoculation 164 
(T-1) than in the gastrointestinal content (14 % vs 1 %, p < 0.05). After the gut models 165 
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were batch-cultured for 24 hours (T0) an increased abundance of Proteobacteria (from 166 
an average of 2 % to 27 %) and Firmicutes (from an average of 40 % to 64 %) was 167 
observed in all vessels (p < 0.05 from T-1 to T0 for both bacterial phyla). However, by 168 
T5 the relative abundance of Firmicutes and Bacteroidetes was comparable to that of 169 
the gastrointestinal content; and the relative abundance of Proteobacteria was much 170 
reduced relative to T0 (from an average of 37% to 8%, p < 0.05).  171 
 On average, samples taken directly from the cecum were composed of 40 % 172 
Bacteroidetes and 46 % Firmicutes (as a mean of the three horses sampled).  173 
Whereas, in the gut model these proportions of bacteria were 21 % and 59 % (as an 174 
average for vessel 1 of the three models of the concordance study), respectively. For 175 
right ventral colon the proportions were 40 % and 47 % for the gut contents and  15 % 176 
and 53 % in the gut model (vessel 2), respectively and for the left ventral colon the gut 177 
contents proportions were 37 % and 50 % and gut model proportions 25 % and 48 %, 178 
respectively (vessel 3).  179 
 Interestingly, the percentage of the bacterial community within the in vitro gut 180 
model that was identified as Bacteroidetes decreased further down the model (from 181 
vessel 1 to 3), similar to the changes observed in aboral regions of the large colon. 182 
There were higher levels of Bacteroidetes in vessel three of model one (M1V3), than 183 
in vessel three of the other two models (M2V3 and M3V3). There was a higher relative 184 
abundance of Synergistetes in the gut model at T5 (mean of all three vessels = 14 %) 185 
compared to the gastrointestinal content (< 1%). There were also slight differences in 186 
bacterial communities of the three models (M1, M2 and M3), inoculated with feces 187 
from different horses. M2 had a significantly higher percentage of reads identified as 188 
Firmicutes compared to M3 (p < 0.05) and M3 had a significantly higher percentage of 189 
Verrucomicrobia and Synergyistetes bacteria than the other two models (p < 0.05). 190 
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 The mean SCFA/BCFA concentration and bacterial phyla count for each vessel 191 
of the concordance study gut models were used to build regression models. A number 192 
of the models built showed a positive correlation between SCFA/BCFA and bacterial 193 
phyla with good model fit (R2 = 0.5). However only a few of these associations were 194 
significant (p < 0.05) these included: Fusobacteria and acetate (V1), Synegistetes and 195 
valerate (all vessels) and Synegistetes and isobutyrate (V1 and V3). For R2 and p 196 
values for regression analyses see Table S2. 197 
 Bacterial community profiles were also illustrated at class and order level 198 
(Figure S4). The bacterial class Clostridia (on average 47 % in gastrointestinal 199 
samples and 53 % average in T5 gut model samples) and order Clostridiales (47 % 200 
and 53 %) were at the same percentage abundance as the Firmicutes phylum (48 % 201 
and 53 %) and the class Bacteroidia (37 % and 21 %) and order Bacteroidales (37 % 202 
and 21%) were at the same percentage abundance as Bacteroidetes phylum (39 % 203 
and 21 %) in all gastrointestinal and gut model samples. Differences associated with 204 
differing relative abundance of Clostridia/Clostridiales and Bacteroidia/Bacteroidales 205 
were observed between the gut models inoculated with different feces. 206 
 207 
 Venn diagrams were produced to visualise the number of distinct operational 208 
taxonomic units (OTUs, bacterial groups with different taxonomic classification) that 209 
were shared between the three vessels of the gut models (at T5) of the concordance 210 
study and their corresponding region of the equine large intestine (Figure 4). Vessel 3 211 
shared the highest number of OTUs, with 57 OTUs (59 % of the total OTUs identified 212 
in samples from vessel 3) being common between vessel 3 and content from the left 213 
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ventral colon. Vessel 2 shared 53 OTUs (56 %) with the right ventral colon samples 214 
and vessel 1 shared 47 OTUs (57 %) with cecum samples.  215 
 216 
The metabolic and microbial profile created by the equine gut model is 217 
repeatable. 218 
The concentration of the five SCFA/BCFA measured using gas chromatography 219 
significantly rose between T-1 and T1 in all of the vessels of the two gut models of the 220 
repeatability study, before plateauing (p < 0.05, Figure 5). As with the concordance 221 
study, the models from the reproducibility study were deemed to be stable by T5 (p > 222 
0.05 for all SCFA/BCFA between T3 and T5). The concentration of butyrate and 223 
valerate slightly decreased after steady state was reached (between T5 and T7), but 224 
this was not significant (p > 0.05). Furthermore, the concentration of the five 225 
SCFA/BCFA measured by gas chromatography was not significantly different in the 226 
two models of the repeatability study (p > 0.05 for all SCFA/BCFA at all turnovers). 227 
 The reproducibility of the metabolic signature of the two gut models was 228 
assessed by building a PCA model with the 1H NMR spectra gained from the two gut 229 
models of the repeatability study (R2 = 0.75, Figure S5). The largest source of variation 230 
within this dataset (PC1, representing 63 % of the total variance in the model) was the 231 
increase in concentration of propionate and acetate over the first four days of the 232 
model (T-1 to T1). Points representing samples from the two different models clustered 233 
together after T1, indicating that the two models were metabolically similar. 234 
 Total bacteria counts calculated by FISH were similar in the two gut models of 235 
the repeatability study (M4 and M5). M4 had slightly more bacteria in all three vessels 236 
at T5 compared to M5 (mean bacteria per ml for M4 was 4.02 x 108 and M5 was 3.88 237 
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x 108), but this was not statistically significant (p > 0.05). There was a slight increase 238 
in total bacteria between T5 and T7 in all of the vessels of the two gut models of the 239 
repeatability study (on average the total bacteria of all vessels increased by 3.74 x 240 
107), but this was not statistically significant (p > 0.05). 241 
 The bacterial alpha diversity (measured as observed OTUs) within the models 242 
at T0, T5 and T7 was significantly lower than the bacterial diversity of the fecal sample 243 
used as inoculum and the model at T-1 (p < 0.05, Figure S3B). However, bacterial 244 
diversity in the models did not significantly change between T5 and T7 (p > 0.05). 245 
Bacterial community profiles were constructed for the two gut models of the 246 
repeatability study to assess reproducibility of the equine gut model (Figure 6). There 247 
were no significant differences between the two models when the bacterial phyla 248 
identified in each of the three vessels at models at T5 were compared (p > 0.05). There 249 
were also no significant differences between the bacterial phyla profile of each vessel 250 
at T5 and T7 (p > 0.05). Bacterial community profiles at class and order level were 251 
similar between the two models of the repeatability study and stable between T5 and 252 
T7 (Figure S6). 253 
 254 
DISCUSSION  255 
We have presented a description of an in vitro model of the equine hindgut and have 256 
examined it against intestinal content samples taken from euthanized horses. This 257 
allowed for the assessment of the equine gut model’s ability to maintain bacterial 258 
communities representative of that found in vivo, the  repeatability of the gut model 259 
setup and the model’s ability to capture individual variation that exists in the gut 260 
microbial communities of horses. Models, by definition, are not exact representations 261 
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of reality. We acknowledge that a model of the equine microbiota will never be an 262 
exact replica of the real bacterial community within the equine large intestine. The 263 
model will however replicate aspects of the microbial community to allow interrogation 264 
and experimental manipulation in a more convenient and less invasive way. Data 265 
presented in this paper demonstrate the strengths and limitations of this novel gut 266 
model system and its potential to extend our understanding of equine intestinal health. 267 
 The three equine gut models of the concordance study showed that the fecal 268 
bacteria introduced to the gut model were able to metabolize the gut model media and 269 
produce SCFA/BCFA. Immediately after inoculation with feces, the abundance of 270 
acetate and propionate within the model increased sharply. Butyrate, isobutyrate and 271 
valerate were not observed to notably increase over the first 24 hours. However, these 272 
three SCFA/BCFA rose sharply in all three vessels during the first three days of being 273 
fed with media. Differences in the timing of SCFA/BCFA appearance may reflect 274 
differential acclimatization of the fecal bacterial communities to the gut model 275 
environment; bacterial communities producing acetate and propionate adapting to the 276 
environment more rapidly than those producing butyrate, isobutyrate and valerate. By 277 
T5, production of all five SCFA/BCFA had stabilized and the models were deemed to 278 
have entered “steady state”. In human gut model studies this is the point at which a 279 
food supplement or drug intervention is added to be studied (10,23–26).  280 
Multivariate statistical models were used to identify metabolic differences 281 
between gastrointestinal content and the gut models. Ethanol, valerate, iso-valerate, 282 
propionate, DEG and TMA were at higher concentrations in the gut model at steady 283 
state compared to gastrointestinal content. Choline can be degraded by the gut 284 
microbiota to liberate ethanol and TMA. Ethanol can also be produced via the 285 
metabolism of keto acids and saturated fatty acids following the microbial breakdown 286 
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of amino acids. Similarly, iso-valerate arises from the microbial degradation of leucine. 287 
These findings indicate that the functional capacity of the equine gut microbiota to 288 
liberate amino acids from ingesta is preserved in the gut model system. The 289 
accumulation of theses metabolites is most likely due to the lack of absorption in the 290 
vessels of the gut model system. However, acetate was present in lower amounts in 291 
the equine gut model compared to gastrointestinal contents. Acetate is a product of 292 
bacterial carbohydrate fermentation and is usually absorbed by the gut wall so it can 293 
undergo further metabolism to generate ATP. Acetate concentrations in V1 of the 294 
concordance study models were found to be significantly positively correlated with the 295 
presence of known acetate producing bacterial phyla, Fusobacteria (27,28). Lower 296 
levels of acetate in the gut model suggest that carbohydrate availability may be less 297 
in the gut model or that some of the carbohydrate-fermenting bacteria cannot be 298 
supported. Alternatively, the acetate produced could be washed through the gut model 299 
system into the waste by the constant flow of media. The high levels of acetate in 300 
gastrointestinal content emphasises the importance of acetate-generating bacteria to 301 
enable horses to liberate energy from their diet. 302 
 FISH analysis of samples of gastrointestinal content and the vessels of the 303 
concordance study gut models provided an estimate of the number of total bacteria in 304 
the two sample types. The mean concentration of bacteria in vessel one was higher 305 
than that seen in the cecum, but this was also the vessel in which total bacteria varied 306 
the most between the three gut models from the concordance  study. The differences 307 
in total bacteria between the three vessels was similar to that seen in the three sample 308 
sites of the large intestine although they are more pronounced in the gut model. This 309 
may be due to the progressive nutrient depletion as media passes through the model 310 
system. 311 
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 We chose to use 16S gene sequencing for taxonomic characterisation of the 312 
bacterial communities present in the model. The advantages of this method are 313 
efficiency and breadth of coverage but we also recognise the disadvantage of limited 314 
resolution and specificity. A more balanced approach for future studies might include 315 
the use of quantitative PCR for targeted taxonomic (and functional) markers of interest. 316 
Future characterisation of this model system could also include evaluation of the 317 
virome and mycobiome. 318 
 Bacterial community profiles of the gastrointestinal content samples that we 319 
used were consistent with those reported previously (5) and dominated by 320 
Bacteroidetes and Firmicutes. Immediately after inoculation all three vessels of the gut 321 
models had a similar composition to fecal samples. After the first 24 hours of 322 
fermentation between T-1 and T0, there is a shift in the bacterial populations, where 323 
Proteobacteria and Firmicutes become dominant. However, by T5 the percentage of 324 
Firmicutes and Bacteroidetes bacteria in the three vessels did not significantly differ 325 
from the equivalent regions of the large intestine and the initial Proteobacteria 326 
overgrowth was reduced.  327 
It is worth noting, however, that not all the populations present in gut content 328 
samples were restored in the model on reaching steady state. This situation will be 329 
largely dictated by the diet of the horse providing samples for inoculation of the model 330 
system, as compared to the nutrients available within the model media. Varying the 331 
carbon and nitrogen sources in the media could aid the growth of a more diverse range 332 
of organisms. Change in bacterial community dynamics have been observed in human 333 
gut models by varying media composition and model retention time (8). In equine and 334 
human gut model systems, the media flowing through the model means that different 335 
nutrient availability occurs in different regions, enabling different environmental 336 
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conditions to be modelled, supporting growth of different microbial populations at 337 
different enteric sites.  338 
 The bacterial profile for vessel three of model one (M1V3) seen in Figure 3 had 339 
a higher percentage of Bacteroidetes than expected; the percentage of Bacteroidetes 340 
usually decreases from vessel two to vessel three (as can be seen in M2 and M3). 341 
This high level of Bacteroidetes is likely to relate to the starting bacterial community in 342 
this horse, as all models were treated identically, except for inoculation with feces from 343 
different horses. The ability of this in vitro system to replicate aspects of bacterial 344 
community profile representative of the equine large intestine is consistent at phylum, 345 
class and order level. 346 
Many of the low abundance bacterial taxa identified in the gastrointestinal 347 
content were absent from the gut model. Significant differences were found when 348 
comparing the OTUs identified in the gut models at T5 to the areas in the large 349 
intestine that they represent. These OTUs may correspond to non-viable bacteria that 350 
were detected in the gastrointestinal content and feces of horses, but were not able to 351 
survive and proliferate in the gut model. Alternatively, it may reflect the failure of the 352 
model to provide the exact environmental conditions needed to support the vast 353 
number of low abundance bacterial groups normally found within the horse large 354 
intestine. Clearly, a limitation of this model is that it does not support growth and 355 
function of all the taxonomic diversity present in the large intestine of horses. To allow 356 
a more diverse bacterial community to establish, other features of the equine large 357 
intestine may need to be added to the model, such as epithelial cells and gut wall 358 
secretions.By visualizing the unique OTUs that are shared between the gut model 359 
vessels and the gastrointestinal content in a Venn diagram, we can see that the gut 360 
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models were able to maintain the bacteria that contribute to 39 – 43% of the unique 361 
OTUs identified in the gastrointestinal samples of horses. 362 
Our studies have indicated that the equine gut model may capture some 363 
aspects of inter-individual variation seen in the gut microbiota of equine populations. 364 
Inoculating models with feces from different horse donors resulted in different bacterial 365 
community profiles by the time steady state is reached. This important aspect of the 366 
model is worthy of further investigation as it may allow the exploration of individual 367 
responses to food supplements and susceptibility to diseases that are mediated via 368 
the gut microbiota. 369 
In the repeatability study two identical gut models were inoculated with feces 370 
from the same horse. SCFA/BCFA levels measured by gas chromatography showed 371 
that their production was similar in the two gut models of the repeatability study. 1H 372 
NMR analysis of supernatants from these two models showed that metabolic profiles 373 
of the vessels were similar at all time points after T1. FISH analysis estimating the total 374 
number of bacteria maintained by the two models showed that differences in total 375 
bacteria between the three vessels were similar across the models. Bacterial DNA 376 
sequencing of samples taken from the three vessels of these two models at T5 showed 377 
comparable taxonomic profiles at both phylum and class level. Bacterial community 378 
profiles were stable for the two models between T5 and T7. The repeatability study 379 
provides preliminary evidence that models inoculated with the same fecal matter will 380 
produce microbial communities that are similar, both structurally and functionally. 381 
We have reported the analyses used to assess the microbial and metabolic 382 
output of a three stage equine gut model. The model is metabolically functional and is 383 
able to support a bacterial community which replicates aspects of that found in the 384 
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equine large intestine. This model is not an exact replication of in vivo bacterial 385 
community of the equine large intestine, but does provide an in vitro alternative to 386 
studies that involve invasive or post-mortem sampling of horses. These may be 387 
particularly valuable for studying cecal microbiota, for which feces are not an adequate 388 
proxy. This model has the potential to aid in the understanding of how the equine gut 389 
microbiota is affected by diet, disease and drugs. 390 
 391 
MATERIALS AND METHODS 392 
Equine gastrointestinal content collection. 393 
Samples of gastrointestinal content were obtained from horses, free of gastrointestinal 394 
disease, no more than three hours after euthanasia. The whole gastrointestinal tract 395 
was removed from the carcass and the large intestine identified. From each horse, 396 
two, 12 ml tubes were filled with content from the following areas: cecum, left ventral 397 
colon, right ventral colon and feces from the end of the small colon. Measurement of 398 
pH of fresh gut contents at all sample sites was achieved using a calibrated, hand-399 
held pH monitor. Samples were transported on dry ice, then stored at -80 °C prior to 400 
analysis. Descriptive details of all horses sampled can be found in Table S1.  401 
 402 
Compositional analysis of gastrointestinal content. 403 
To inform the make-up of media ADF and starch content of gastrointestinal samples 404 
from three UK leisure horses (horse 1, 2 and 3 in Table S1) were analyzed. Samples 405 
were all free-dried to remove all moisture. ADF content of free-dried samples were 406 
analyzed using the filter bag technique (ANKOM technology). Starch content of 407 
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samples were analyzed by converting starch into glucose by treatment of the hot water 408 
extract with amyloglucosidase followed by acid hydrolysis (29). Total reducing sugars 409 
were measured colormetrically according to Fuller 1967 (30). 410 
 411 
Three stage continuous culture system. 412 
The human gut model developed by Macfarlane et al. 1998 (8) was adapted with the 413 
aim of replicating the microbiota of the cecum, right ventral colon and left ventral colon 414 
of the equine large intestine (Figure 7). This continuous culture system constituted of 415 
three vessels (V1, V2 and V3) with respective volumes of 300 ml, 400 ml and 200 ml 416 
to provide a scaled down version of their respective regions of the equine 417 
gastrointestinal tract. Temperature (at 38 °C by circulating water bath; Optima) and pH 418 
were automatically controlled (by Broadly James F695 pH probes and Fermac 260 pH 419 
measurement and control module; Electrolab) as described in Macfarlane and Eglyst 420 
(31). V1 and V2 were maintained at pH 6.3 - 6.5 and V3 at pH 6.6 - 6.8 to reflect the 421 
pH of the cecum, right ventral colon and left ventral colon respectively. All vessels and 422 
the media reservoir were stirred by magnetic fleas and maintained under anaerobic 423 
conditions by a continuous flow of anaerobic mix gas (80% N2, 10% CO2 and 10% H2). 424 
A single channel, variable speed peristaltic pump (Electrolab) fed vessel one with 425 
media from the media reservoir at a rate of 900 ml every three days which represented 426 
the scaled flow rate of ingesta through the equine gastrointestinal tract. Media then 427 
flowed from vessel one to two and vessel two to three through the waste pipe of each 428 
vessel. 429 
The human gut model media from MacFarlane et al. 1998 (8) was altered to 430 
mirror the ADF and fibre content seen in compositional analysis of gastrointestinal 431 
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content (Figure S1). To represent the normal diet of a horse the percentage of starch 432 
and fibre were increased and the percentage of protein decreased. The composition 433 
of this media in distilled water was: cellulose (15 g litre-1), yeast extract (5 g litre-1), 434 
NaCl (5 g litre-1), KCl (5 g litre-1), mucin (4 g litre-1), raffinose (3.5 g litre-1), starch (2 g 435 
litre-1), peptone water (1.5 g litre-1), tryptone (1.5 g litre-1), NaHCO3 (1.5 g litre-1), 436 
MgSO4(.7H2O) (1.25 g litre-1), arabinogalactan (1 g litre-1), xylan (0.835 g litre-1), 437 
cysteine.HCl (0.8 g litre-1), KH2PO4 (0.5 g litre-1), K2HPO4 (0.5 g litre-1), bile salts (0.4 438 
g litre-1), CaCl2.6H2O (0.15 g litre-1), hemin (0.05 g litre-1), FeSO4.H2O (0.005 g litre-1), 439 
tween 80 (0.5 ml litre-1) and vitamin K (0.01 ml litre-1). 440 
To inoculate the gut model a sample of feces was collected from the rectum 441 
post-mortem or immediately after defecation for non-invasive sample acquisition and 442 
placed in a sealed jar, with an anaerobic atmosphere generating sachet (Oxoid 443 
AnaeroGen 2.5 L Sachet; Thermo Fisher) for transportation for a maximum of two 444 
hours. A 20 % fecal slurry (1 x PBS) was made in a strainer stomacher bag (Seward), 445 
by homogenizing fecal balls manually within an anaerobic cabinet (Whitley A35 446 
anaerobic workstation). 100 ml, 133 ml and 67 ml of the fecal slurry was decanted and 447 
added respectively to each vessel (sample taken immediately after inoculation were 448 
designated T-1). After the fecal slurry was added  the model was allowed to equilibrate 449 
as a batch culture for 24 hours. The media pump was started after 24 hours, 450 
designated T0. The short period of batch culture allowed the fecal bacteria to 451 
acclimatise to their new environment and reduce the washing-out of bacteria when the 452 
flow of media was started. 453 
A sample of 5 ml was taken through the sample port of each vessel at T-1, T0 454 
and every subsequent full turnover of media through the model (every three days). 455 
Two aliquots of 1 ml were centrifuged at 11,337 g, the supernatant stored at -20 °C 456 
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and pellets stored at -80 °C. For preparation of FISH slides, an aliquot of 375 µl from 457 
each sample was added to 1125 µl 4 % paraformaldehyde (PFA) and incubated at 5 458 
°C for four hours. PFA was washed off with 1 x PBS, the pellet re-suspended in 150 459 
µl 1 x PBS and 150 µl ethanol and stored at -20 °C until required. Processing of all 460 
samples was carried out in an anaerobic cabinet (Whitley A35 anaerobic workstation). 461 
 462 
Concordance and repeatability studies. 463 
The concordance study used three gut models (M1, M2 and M3) inoculated with feces 464 
from three different horses to assess the similarity between the gastrointestinal 465 
samples and the stabilised fermentation model of the same horse. Modelling three 466 
different individuals allowed assessment of whether the model could capture the inter-467 
individual variation seen in vivo. Samples of gastrointestinal content were taken post 468 
mortem from the cecum, right ventral colon, left ventral colon and feces from the 469 
rectum of three horses (Horses 4, 5 and 6 in Table S1). These samples were 470 
transported on dry ice and then stored at -80 °C until defrosted for analyses. A further 471 
100 g of feces were taken from of each horse and stored in an anaerobic jar (Oxoid) 472 
with an anaerobic gas generating sachet until it was used to make a 20 % fecal slurry 473 
used to inoculate all vessels. Each gut model was sampled every turnover until steady 474 
state was reached (T5, when SCFA production stabilised). 475 
Subsequent to this, two gut models (M4 and M5) were run at the same time 476 
with feces from the same horse, for the repeatability study. This aimed to assess the 477 
reproducibility of the metabolic and bacterial signatures between different gut models. 478 
Freshly voided feces were collected from a healthy horse (Horse 7 in Table S1) and 479 
transported in a sealed container with an anaerobic gas generating sachet to use for 480 
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fecal slurry inoculum. These models were run until turnover seven (T7) to assess 481 
stability of the model after steady state (T5) was reached and samples were taken and 482 
processed as previously described. An overview of the inoculation and sampling of the 483 
concordance and repeatability studies can be seen in Figure 8. 484 
 485 
SCFA/BCFA analysis by Gas Chromatography. 486 
Supernatants from all gut models at all time points underwent gas chromatography to 487 
analyse the levels of acetate, propionate, butyrate, isobutyrate and valerate. These 488 
samples were analysed using an acidification method adapted from Zhao et al. 2006 489 
(32). Samples were filtered through 0.2 mm PVDF filer and acidified to pH 2 using 490 
sulfuric acid. An internal standard of 2-ethyl butyrate was added to at 5 mM in each 491 
sample.  A fused-silica capillary column with a free fatty acid phase (DB-FFAP) was 492 
used; with helium as the carrier gas, flow rate of 14.4 ml/min. The initial oven 493 
temperature was 100 °C, which was held for 2 minutes before being raised to 180 °C 494 
at 8 °C per minute and held for a further 2 minutes, then increased to 200 °C at 20 °C 495 
per minute, and held at 200 °C for 5 minute. A range of standards were used at 496 
concentrations from 0.5mM to 100mM, these contained acetate, propionate, butyrate, 497 
iso-butyrate, valerate and isovalerate. Analysis of peak areas was done using 498 
ChemStation B.03.01 software (Aligent Technologies).  499 
Human gut models are often run for eight turnovers (24 days) before they are 500 
deemed to reach steady state (assessed by stabilization of SCFA levels) and a drug 501 
or feed intervention added (e.g. Grimaldi et al. 2017). We chose to use SCFA 502 
production as a marker for model stability, plateauing of production indicating 503 
achievement of steady state (Fig 1). Accordingly, community profiling models were run 504 
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until T5 (15 days after media flow was started) as SCFA production was deemed to 505 
be stable at this time point; the repeatability study was run for a further two turnovers 506 
after this point to further assess the stability of the model. Gut models maintained for 507 
longer time-periods (data not reported here) have confirmed stability of SCFA 508 
production until T7 (1 days after media flow was started).  509 
 Kruskal-Wallis tests were performed to assess the stability of the SCFA 510 
produced by the vessels of the concordance study gut models from T3 to T5 to assess 511 
if steady state had been reached. Kriskall-Wallis tests were  also used to assess the 512 
stability of SCFA production in the repeatability study gut models from T3 to T5, from 513 
T5 to T7 and whether there were any differences in SFCA production between the two 514 
models created with the same fecal inoculum (repeatability study). 515 
 516 
 1H NMR spectroscopy. 517 
Sample supernatants taken from the model were prepared for 1H NMR analysis by 518 
adding 200 µl of phosphate buffer (pH 7.4; 100 % D2O) containing 1 mM of the internal 519 
standard 3-trimethylsilyl-1-[2,2,3,3-2H4] propionate (TSP) to 400 µl of each sample 520 
and transferred into 5 mm NMR tubes. Spectroscopic analysis of all samples was 521 
carried out on a 700 MHz Bruker NMR spectrometer equipped with a cryo-probe. 522 
Standard one-dimensional 1H NMR spectra were acquired for all samples with water 523 
peak suppression using a standard pulse sequence. For each sample, 8 dummy scans 524 
were followed by 256 scans and collected in 64K data point. Chemical shifts in the 525 
fecal spectra were referenced to the TSP singlet at δ 0.0. Scans collected 64K data 526 
points. A spectral width of 20 ppm and an acquisition time per scan of 3.12 seconds 527 
were used. 528 
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1H NMR spectra were analysed in the Matlab environment (R2014a; 529 
Mathworks) with in-house scripts. Spectra were initially aligned and normalized 530 
(probabilistic quotient method) before multivariate models were built to compare the 531 
metabolic profiles of gastrointestinal content to sample supernatants from the gut 532 
model. Initial unsupervised PCA models were constructed to identify metabolites that 533 
explain the largest sources of variation within the dataset. OPLS-DA models were 534 
constructed for pair-wise comparisons of gastrointestinal content and gut model 535 
supernatants. The predictive ability (Q2Y) of the OPLS-DA models were calculated 536 
using seven-fold cross validation. Metabolites were assigned to peaks using the 537 
database of equine metabolites found in Escalona et al. (33). 538 
 539 
FISH analysis for total bacteria. 540 
FISH was used alongside 16S gene sequencing in order to enumerate total bacterial 541 
numbers. It provides a validated approach for counting microbial numbers using 542 
probes targeting specific bacterial taxa. FISH analyses were carried out by a trained 543 
operator; quality assurance was provided by duplicate counting by second operator 544 
which gave rise to comparable results (greater than 95% confidence of similarity). 545 
Total bacterial count per ml was calculated by utilising Eubmix FISH probe. This is a 546 
mixture of three EUB338 probes (I, II and III, Sigma Aldrich) with the dye Cy3 tagged 547 
at the 5’ end. Hybridisation was performed as described in Daims et al. 1999 (34). All 548 
samples prepared for FISH were diluted to 1 in 100 (in PBS:SDS) and 20 µl was added 549 
to a well of Teflon- and poly L-lysine-coated 6-well slide (Tekdon Inc.). Slides were 550 
dried on a plate incubator for 15 minutes at 46 - 50 °C, dehydrated in 30 %, 80 % and 551 
96 % ethanol for 3 minutes each and then dried for 2 minutes. Hybridisation mixture 552 
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(0.9 M NaCl, 0.02 M Tris/HCl (pH 8), formamamide, 10 % sodium dodecyl sulphate 553 
and 4.55 ng ml-1 probe) was added to each well, slides placed on a sealed tray and 554 
put in a hybridisation oven for 4 hours at 46 °C. Once hybridisation was complete 555 
slides were placed into wash buffer (0.9 M NaCl, 0.02 M Tris/HCl (pH 8) 0.005 M EDTA 556 
solution (pH 8), H2O) for 10 - 15 minutes at 48 °C. After washing slides were dipped 557 
into cold water for 2 - 3 seconds and dried using compressed air. Once dry, antifade 558 
solution (Dabco) was added to each well and a cover slip applied. Fixed bacteria were 559 
visualised using fluorescence microscopy (Nikon Eclipse Ni-U microscope), the 560 
number of bacteria counted in 15 random fields of view per well and a mean calculated. 561 
To calculate the number of bacteria per ml the following equation was used: 562 
𝐵𝑎𝑐𝑡𝑒𝑟𝑖𝑎 𝑝𝑒𝑟 𝑚𝑙 = 0.8 × 𝑚𝑒𝑎𝑛 𝑏𝑎𝑐𝑡𝑒𝑟𝑖𝑎 × 6788.42 × 50 × 100 563 
 564 
Preparation and analysis of bacterial DNA sequencing. 565 
DNA was extracted from frozen gastrointestinal samples and pellets from the gut 566 
model using PSP® spin stool DNA plus kit (Invisorb) using the manufacturer’s 567 
protocol. Extracted DNA was re-suspended in 100 µl of elution buffer. Further 568 
preparation and DNA sequencing was carried out by the Centre of Genomic Research, 569 
Liverpool. The extracted DNA was amplified using PCR of the V4 region of the 16S 570 
rRNA gene using the primers F515 (GTGCCAGCMGCCGCGGTAA) and 806R 571 
(GGACTACHVGGGTWTCTAAT) (35), with reverse primers containing individual 572 
Golay barcodes.  For a final volume of 20 µl to be subjected to V4 PCR 1 µl of the 573 
extracted DNA from each sample was added to: 7 µl of molecular water, 10 µl 574 
NEBNext High Fidelity Master Mix (New England Biolabs), 1 µl of forward primer (3 575 
µM) and 1 µl of an individually barcoded reverse primer (3 µM). This mixture was made 576 
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for each individual sample, which then underwent the following PCR conditions: 30 577 
seconds at 98 °C and 25 cycles of: 10 seconds at 98 °C, 30 seconds at 55 °C and 30 578 
seconds at 72 °C. This was followed by a final period of 5 minutes at 72 °C and then 579 
kept at 4 °C until processed. PCR products were evaluated by electrophoresis in 2 % 580 
agarose gel stained with midori green. Successfully amplified DNA was cleaned using 581 
AMPure XP beads (Agencourt) and quantified using the Quant-iT PicoGreen dsDNA 582 
assay (Life Tech). PCR products were pooled at an equimolar ratio and size selected 583 
using a 2 % agarose gel cassette run in a Pippin Prep (Sage Science machine) where 584 
fragments at 254 bp were eluted and kept for sequencing. Sequencing was carried out 585 
on the MiSeq Illumina platform. 586 
 Analysis of sequencing data was carried out on a remote linux server provided 587 
by the University of Surrey with QIIME2 (36) installed. Zipped read files were uploaded 588 
to the linux server and converted into a QIIME artefact (qiime tools import) and a 589 
summary was generated (qiime demux summarize). Quality control was carried out 590 
using DADA2 (37) and the ends of reads were trimmed at position 15 and 220 of the 591 
reads (qiime dada2 denoise-single). A rooted phylogenetic was generated for diversity 592 
analyses (qiime alignment mafft, qiime alignment mask, qiime phylogeny fasttree and 593 
qiime phylogeny midpoint-root). Diversity core metrics were generated at a sampling 594 
depth of 47,000 reads (qiime diversity core-metrics-phylogenetic) and boxplots 595 
displaying alpha diversity (measure as observed OTUs) were generated (qiime 596 
diversity alpha-group-significance). The reference database greengenes (38) was 597 
downloaded and the taxanomic classifiers were trained on this specific sample 598 
preparation and sequencing parameters (qiime feature-classifier classify-sklearn). 599 
Taxa summary barplots were generated (qiime taxa barplot). 600 
 601 
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Mann-Whitney U tests were used to assess whether read numbers for identified 602 
bacterial phyla were statistically different when comparing gastrointestinal content to 603 
the gut model and time points of the model. Regression models were built with the 604 
mean SCFA/BCFA concentration and bacterial phyla count for the each vessel of the 605 
concordance study at T-1, T0 and T5. Correlations identified by the models were 606 
deemed to be significant when R2 = 0.5 and p < 0.05. Venn diagrams were generated 607 
to visualise how many identifiable and uniquely named OTUs were shared between 608 
the vessels of the three biological replicate gut models and their corresponding 609 
gastrointestinal compartments. 610 
Raw sequencing reads analysed in this manuscript have been submitted to the 611 
European Nucleotide Archive and can be found in project ERP107630. 612 
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Figures 756 
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Figure 1: Demonstration of biological functionality of the gut models in the 757 
concordance  study. SCFA/BCFA production of the three separate gut models 758 
inoculated with feces from three different horses during the concordance study 759 
(shown as the mean and standard deviation of the three vessels of the model). The 760 
SFCA/BCFAs measured were: A) acetate, B) propionate, C) butyrate, D) isobutyrate 761 
and E) valerate. T, turnover; V, vessel. 762 
 763 
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Figure 2: Biochemical variation (measured by 1H NMR spectroscopy) between the gut 764 
contents of donor horses and in-vitro gut model supernatant from the concordance 765 
study. A) PCA scores plot for PC1 and PC2 of the model (R2 = 0.64). B)The loading 766 
plot for PC1, describing 50 % of the total variance associated with higher concentration 767 
of acetate in model supernatant at time poinrs T1 – T5 and C) the loading plot for PC2 768 
describing 14 % of the total variance, associated with higher acetate concentration in 769 
gut contents. PC, principle component; T, turnover. 770 
 771 
 772 
 773 
Figure 3: Relative abundance of the bacterial phyla (assigned by 16S bacterial gene 774 
sequencing)  identified in the gastrointestinal content from donor horses and the three 775 
35 
 
gut models from the concordance  study. The key indicates whether bacterial phyla 776 
are: identified in both gastrointestinal and gut model samples at T5 (black), only in 777 
gastrointestinal samples (blue) or only in gut model samples (red). 778 
C, cecum; RVC, right ventral colon; LVC, left ventral colon; V, vessel; T, turnover; M, 779 
model.  780 
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Figure 4: Venn diagram showing the total number of distinct OTUs that are unique 781 
and shared between samples taken from the areas of the equine large intestine and 782 
their corresponding vessels from the gut models. These models were from the 783 
concordance study used to capture individual variation. 784 
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Figure 5: Demonstration of repeatability of biological function between models. 785 
SCFA/BCFA production (measured by gas chromatography) in each vessel of the 786 
models was inoculated with the same feces (repeatability study). Each line represents 787 
the level of a SCFA/BCFA in a single vessel of one of the two gut models of the 788 
repeatability study. The SFCA/BCFAs measured were: A) acetate, B) propionate, C) 789 
butyrate, D) isobutyrate and E) valerate. T, turnover; R, technical replicate; V, vessel; 790 
M, model.  791 
Figure 6: Demonstration of the repeatability of model bacterial communities. 792 
Taxonomic assignments (phyla from 16S bacterial gene sequencing) from the 793 
repeatability study; two models inoculated with feces from the same horse. M, model; 794 
V, vessel; T, turnover. 795 
 796 
 797 
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Figure 7: Three stage, in vitro, fermentation model designed to replicate the 815 
microbiota of the equine cecum, right ventral colon and left ventral colon (modified 816 
from MacFarlane et al. 1998). 817 
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Figure 8: Schematic showing the sampling scheme and experimental design for A) 818 
concordance study to demonstrate capture of inter-individual variation and B) 819 
repeatability study to demonstrate consistency of models inoculated with the same 820 
feces. 821 
 822 
Supplementary Figures 823 
Figure S1: The average percentage of ADF (acid detergent fiber) and starch within 824 
the gut content from five areas of the equine gastrointestinal system from three horses 825 
(1, 2 and 3 in Table S1). Error bars show standard deviation of the values within each 826 
group. 827 
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Figure S2: Comparison of metabolic profiles of ex vivo gut content and the gut model 828 
at steady state (T5). Multivariate models built with the 1H NMR spectra from samples 829 
of GI content and samples from all vessels of the three separate gut models in the 830 
concordance study (inoculated with feces from different horses). A PCA model (R2 = 831 
0.64) was built and A) scores plot and B) the loading plot for PC1 (representing 48 % 832 
of the total variance in the dataset) was visualised. C) The correlation coefficient plot 833 
from the OPLS-DA model built with these spectra (Q2Y = 0.82). PC, principle 834 
component; DEG, diethylene glycol; TMA, trimethylamine. 835 
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Figure S3: Alpha rarefaction boxplots showing bacterial diversity of the 836 
gastrointestinal contents/feces and the time points of the gut models of: A) the 837 
concordance study and B) the repeatability study. 838 
 839 
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Figure S4: Relative abundance of bacterial A) classes and B) orders identified in 840 
samples from the GI content and all vessels the three gut models of the concordance 841 
study (inoculated with feces from three different horses). The key indicates whether 842 
bacterial phyla are: identified in both gastrointestinal and gut model samples at T5 843 
(black), only in gastrointestinal samples (blue) or only in gut model samples (red). C, 844 
cecum; RVC, right ventral colon; LVC, left ventral colon; V, vessel; T, turnover. 845 
 846 
 847 
 848 
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 850 
Figure S5: Demonstration of the repeatability of the metabolic profiles of the gut 851 
models from the repeatability study. PCA model constructed with the 1H NMR spectra 852 
gained from the all vessels of the two gut models inoculated with the feces from the 853 
same horse (R2 = 0.75). A) The PCA scores plot for this model and B) the loading plot 854 
for PC1 (representing 63 % of the total variance in the dataset). T, turnover; PC, 855 
principle component; M, model. 856 
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Figure S6: Relative abundance of bacterial A) classes and B) orders identified in 857 
samples from all vessels the two gut models of the repeatability study (inoculated with 858 
feces from the same horse).C, cecum; RVC, right ventral colon; LVC, left ventral colon; 859 
V, vessel; T, turnover; M model. 860 
